137 related articles for article (PubMed ID: 14647269)
1. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
2. The evolution of hematopoietic cells under cancer therapy.
Pich O; Cortes-Bullich A; Muiños F; Pratcorona M; Gonzalez-Perez A; Lopez-Bigas N
Nat Commun; 2021 Aug; 12(1):4803. PubMed ID: 34376657
[TBL] [Abstract][Full Text] [Related]
3. Early occurrence of acute myelomonocytic leukemia (M4/M5) after liver transplantation: a case report.
Zamani F; Karimi H; Mansoorian M; Basi A; Hosseini SA; Zahed Z; Seyedghasemipour N; Sahraie R
J Med Case Rep; 2023 Sep; 17(1):398. PubMed ID: 37667403
[TBL] [Abstract][Full Text] [Related]
4. Consolidative Proton Radiotherapy for Pediatric Extramedullary Ocular Acute Myeloid Leukemia.
Bush A; Eslin DE; Joyce MJ; Hess D; Leon D; Ermoian RP; Mailhot Vega RB
Int J Part Ther; 2024 Mar; 11():100002. PubMed ID: 38757078
[TBL] [Abstract][Full Text] [Related]
5. Acute Shoulder Monoarthritis in a Patient With Acute Myelomonocytic Leukemia With Novel Translocation t(5;13).
Mueller M; Calvo AR
World J Oncol; 2010 Feb; 1(1):50-51. PubMed ID: 29147181
[TBL] [Abstract][Full Text] [Related]
6. Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Stroet A; Hemmelmann C; Starck M; Zettl U; Dörr J; Friedemann P; Flachenecker P; Fleischer V; Zipp F; Nückel H; Kieseier BC; Ziegler A; Gold R; Chan A
Ther Adv Neurol Disord; 2012 Mar; 5(2):75-9. PubMed ID: 22435072
[TBL] [Abstract][Full Text] [Related]
7. Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer.
Petrone G; Gaulin C; Derkach A; Kishtagari A; Robson ME; Parameswaran R; Stein EM
Haematologica; 2023 Jan; 108(1):161-170. PubMed ID: 35770528
[TBL] [Abstract][Full Text] [Related]
8. Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.
Seval GC; Topçuoğlu P; Demirer T
Turk J Med Sci; 2021 Dec; 51(6):2799-2809. PubMed ID: 33705648
[TBL] [Abstract][Full Text] [Related]
9. Getting Lost in the Cell-Lysosomal Entrapment of Chemotherapeutics.
Zhai X; El Hiani Y
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297435
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-cancereffect and innovative approaches in thetreatment of refractory solid tumors.
Şahin U; Demirer T
Turk J Med Sci; 2020 Nov; 50(SI-2):1697-1706. PubMed ID: 32178508
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.
Taylor M; Khan S; Stapleton M; Wang J; Chen J; Wynn R; Yabe H; Chinen Y; Boelens JJ; Mason RW; Kubaski F; Horovitz DDG; Barth AL; Serafini M; Bernardo ME; Kobayashi H; Orii KE; Suzuki Y; Orii T; Tomatsu S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):e226-e246. PubMed ID: 30772512
[TBL] [Abstract][Full Text] [Related]
12. Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.
Atilla E; Ataca Atilla P; Cengiz Seval G; Bektaş M; Demirer T
Turk J Gastroenterol; 2019 Feb; 30(2):122-131. PubMed ID: 30459131
[TBL] [Abstract][Full Text] [Related]
13. A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer.
Karadurmus N; Sahin U; Bahadir Basgoz B; Arpaci F; Demirer T
Int J Hematol Oncol Stem Cell Res; 2018 Apr; 12(2):111-116. PubMed ID: 30233772
[TBL] [Abstract][Full Text] [Related]
14. Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation.
Cengiz Seval G; Topçuoğlu P; Demirer T
Balkan Med J; 2018 Mar; 35(2):131-140. PubMed ID: 29553463
[TBL] [Abstract][Full Text] [Related]
15. A review of infectious complications after haploidentical hematopoietic stem cell transplantations.
Atilla E; Atilla PA; Bozdağ SC; Demirer T
Infection; 2017 Aug; 45(4):403-411. PubMed ID: 28417421
[TBL] [Abstract][Full Text] [Related]
16. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.
Atilla E; Ataca Atilla P; Demirer T
Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017
[TBL] [Abstract][Full Text] [Related]
17. Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer.
Karadurmus N; Sahin U; Basgoz BB; Arpaci F; Demirer T
World J Transplant; 2016 Dec; 6(4):675-681. PubMed ID: 28058217
[TBL] [Abstract][Full Text] [Related]
18. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
Atilla E; Atilla PA; Demirer T
Int J Hematol; 2017 Mar; 105(3):257-264. PubMed ID: 27995456
[TBL] [Abstract][Full Text] [Related]
19. Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.
Atilla E; Toprak SK; Demirer T
Turk J Haematol; 2017 Mar; 34(1):1-9. PubMed ID: 27956374
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
